Will C-Peptide Substitution Make a Difference in Combating Complications in Insulin-Deficient Diabetes?

Editorial

Rev Diabet Stud, 2004, 1(2):55-57

Anders A.F. Sima

Departments of Pathology and Neurology, Wayne State University, 540 E. Canfield Avenue, Detroit, MI 48201, USA, e-mail: asima@med.wayne.edu.

n/a

	Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin Meyer JA, Subasinghe W, Sima AA, Keltner Z, Reid GE, Daleke D, Spence DM Mol Biosyst 2009. 5:1157-1162

	Rosuvastatin positively changes nerve electrophysiology in diabetic rats Tarhzaoui K, Valensi P, Leger G, Cohen-Boulakia F, Lestrade R, Behar A Diabetes Metab Res Rev 2009. 25(3):272-278